Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 13, Issue 7, Pages 989-998
Publisher
Informa Healthcare
Online
2014-06-17
DOI
10.1517/14740338.2014.920820
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment
- (2014) L. Rolf et al. NEUROLOGY
- Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis
- (2014) G. Karlsson et al. NEUROLOGY
- Rebound of disease activity during pregnancy after withdrawal of fingolimod
- (2013) A. P. Sempere et al. EUROPEAN JOURNAL OF NEUROLOGY
- Recurrent Varicella following Steroids and Fingolimod in a Multiple Sclerosis Patient
- (2013) D. Ferraro et al. Journal of Neuroimmune Pharmacology
- Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study
- (2013) Ralf Gold et al. JOURNAL OF NEUROLOGY
- Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient
- (2013) E. Piscolla et al. JOURNAL OF NEUROLOGY
- Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy
- (2013) G Francis et al. Multiple Sclerosis Journal
- Relapse of multiple sclerosis in a patient retaining CCR7-expressing T cells in CSF under fingolimod therapy
- (2013) Akiko Yokoseki et al. Multiple Sclerosis Journal
- Tumefactive MS lesions under fingolimod: A case report and literature review
- (2013) G. Pilz et al. NEUROLOGY
- Rebound of Disease Activity After Withdrawal of Fingolimod (FTY720) Treatment
- (2012) Joachim B. Havla ARCHIVES OF NEUROLOGY
- Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice
- (2012) K. B. Lorvik et al. BLOOD
- Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients
- (2012) A. Ghezzi et al. JOURNAL OF NEUROLOGY
- Multiple sclerosis and pregnancy: therapeutic considerations
- (2012) Maria K. Houtchens et al. JOURNAL OF NEUROLOGY
- Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawal
- (2012) L Daelman et al. Multiple Sclerosis Journal
- Prolonged and symptomatic bradycardia following a single dose of fingolimod
- (2012) Hans Faber et al. Multiple Sclerosis Journal
- Sudden unexpected death on fingolimod
- (2012) JW Lindsey et al. Multiple Sclerosis Journal
- Withdrawal of fingolimod treatment for relapsing–remitting multiple sclerosis: report of six cases
- (2012) Bahia Hakiki et al. Multiple Sclerosis Journal
- Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod
- (2012) Sebastian Jander et al. Multiple Sclerosis Journal
- Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod
- (2012) J. N. Ratchford et al. NEUROLOGY
- Severe relapses under fingolimod treatment prescribed after natalizumab
- (2012) D. Centonze et al. NEUROLOGY
- Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis?
- (2012) P. A. Calabresi et al. NEUROLOGY
- Severe multiple sclerosis relapse under fingolimod therapy: Incident or coincidence?
- (2012) F. Castrop et al. NEUROLOGY
- Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod
- (2012) C. M. Gross et al. NEUROLOGY
- Tumefactive multiple sclerosis lesions under fingolimod treatment
- (2012) F. Visser et al. NEUROLOGY
- Fingolimod-associated macular edema: Incidence, detection, and management
- (2012) N. Jain et al. NEUROLOGY
- Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis
- (2011) Jeffrey A. Cohen et al. ANNALS OF NEUROLOGY
- Melanoma Occurring During Treatment With Fingolimod for Multiple Sclerosis: A Case Report
- (2011) Katrin Baumann Conzett ARCHIVES OF DERMATOLOGY
- Clinical Pharmacokinetics of Fingolimod
- (2011) Olivier J. David et al. CLINICAL PHARMACOKINETICS
- Reduction of the Peripheral Blood CD56bright NK Lymphocyte Subset in FTY720-Treated Multiple Sclerosis Patients
- (2011) T. A. Johnson et al. JOURNAL OF IMMUNOLOGY
- Branch Retinal Vein Occlusion During Fingolimod Treatment in a Patient With Multiple Sclerosis
- (2011) Roberto Gallego-Pinazo et al. JOURNAL OF NEURO-OPHTHALMOLOGY
- Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study
- (2011) Bhupendra Khatri et al. LANCET NEUROLOGY
- Delayed fingolimod-associated asystole
- (2011) Patricio S Espinosa et al. Multiple Sclerosis Journal
- Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
- (2011) Ju-Hong Min et al. Multiple Sclerosis Journal
- Impact of sphingosine 1-phosphate modulation on immune outcomes
- (2011) D. D. Pinschewer et al. NEUROLOGY
- Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone
- (2011) V. Martinelli et al. NEUROLOGY
- Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation
- (2011) T. Hla et al. NEUROLOGY
- Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis
- (2011) M. Mehling et al. NEUROLOGY
- Reconstitution of circulating lymphocyte counts in FTY720-treated MS patients
- (2010) Trina A. Johnson et al. CLINICAL IMMUNOLOGY
- Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
- (2010) David B Clifford et al. LANCET NEUROLOGY
- CRITICAL VASOSPASM DURING FINGOLIMOD (FTY720) TREATMENT IN A PATIENT WITH MULTIPLE SCLEROSIS
- (2010) A. Schwarz et al. NEUROLOGY
- Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
- (2010) M. Mehling et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- HEMORRHAGING FOCAL ENCEPHALITIS UNDER FINGOLIMOD (FTY720) TREATMENT: A CASE REPORT
- (2009) F. Leypoldt et al. NEUROLOGY
- Cyclical and Dose-Dependent Responses of Adult Human Mature Oligodendrocytes to Fingolimod
- (2008) Veronique E. Miron et al. AMERICAN JOURNAL OF PATHOLOGY
- The ability of atropine to prevent and reverse the negative chronotropic effect of fingolimod in healthy subjects
- (2008) John M. Kovarik et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
- (2008) M. Mehling et al. NEUROLOGY
- FTY720 modulates human oligodendrocyte progenitor process extension and survival
- (2007) Veronique E. Miron et al. ANNALS OF NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started